These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 926982)

  • 21. [Treatment of subacute and chronic forms of hepatitis as well as of chronic degenerative liver diseases using Silymarin].
    Zirm KL
    Wien Med Wochenschr; 1973 May; 123(19):302-5. PubMed ID: 4702588
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current approaches to using beta-carotenoids in chronic hepatitis in flight personnel].
    Preobrazhenskiĭ VN; Vasilenko VV
    Aviakosm Ekolog Med; 1996; 30(3):45-6. PubMed ID: 8963295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The action of silymarin on Galactosamine-induced hepatitis in the rat (author's transl)].
    Barbarino F; Suciu A; Cotutiu C; Ban A
    Wien Klin Wochenschr; 1977 Feb; 89(3):90-5. PubMed ID: 189515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of hepatic diseases in ambulatory medicine. Multicenter studies].
    Martines G; Mingrino GC; Cagnetta G; Copponi V
    Clin Ter; 1980 Jan; 92(1):33-58. PubMed ID: 7449307
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of citiolone in chronic hepatitides. Results of a research with clinical and laboratory controls].
    Miglio F; D'Ambro A; Stefanini GF; Corazza GR; Pesa O; Flacco L; Schiavone C; Gasbarrini G
    Minerva Med; 1977 Sep; 68(46):3177-92. PubMed ID: 917333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of (+)-cyanidanol-3 in the treatment of chronic active hepatitis (author's transl)].
    Demeulenaere F; Desmet VJ; Dupont E; Fiasse R; Gisselbrecht H; Heully F; Jeanpierre R; Lecomte J; Lennes G; Macinot C; Migeotte P; Pirotte J; Rauber G; Ruyters L; Van Cauwenberge H
    Gastroenterol Clin Biol; 1981 Mar; 5(3):314-23. PubMed ID: 7014344
    [No Abstract]   [Full Text] [Related]  

  • 27. Liver cell protection in toxic liver lesion.
    Fehér J; Cornides A; Pál J; Láng I; Csomós G
    Acta Physiol Hung; 1989; 73(2-3):285-91. PubMed ID: 2596318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Humoral and cell-bound immunological reactions in chronic hepatitis (author's transl)].
    Maerker-Alzer G; Schumacher K
    Leber Magen Darm; 1975 Aug; 5(4):132-9. PubMed ID: 1083470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autoantibodies to liver membrane in children with chronic active hepatitis (author's transl)].
    Chauvel Y; Fernandez-Tello DS; Frommel D
    Arch Fr Pediatr; 1980; 37 Suppl 2():V-VII. PubMed ID: 7447613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 31. [DNA synthesis in rat liver after repeated administration of E. coli endotoxin--effect of cortisone, fasting and silymarine (author's transl)].
    Simek J; Cervinková Z; Hegerová J; Dvorácková I; Vodicka I
    Cesk Gastroenterol Vyz; 1978 Jan; 32(1):14-20. PubMed ID: 346239
    [No Abstract]   [Full Text] [Related]  

  • 32. [Uses of silymarin in the treatment of symptomatic hepatic porphyria (author's transl)].
    Kordac V; Kaláb M
    Cas Lek Cesk; 1977 Apr; 116(13):407-10. PubMed ID: 861998
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease.
    Lirussi F; Okolicsanyi L
    Acta Physiol Hung; 1992; 80(1-4):363-7. PubMed ID: 1345202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience in the treatment of chronic hepatopathies with silymarin].
    Poser G
    Arzneimittelforschung; 1971 Aug; 21(8):1209-12. PubMed ID: 5110021
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of silymarin and SAMe in the treatment of acute infective hepatitis in childhood].
    Musso A; Giacchino M; Vietti M; Vaccino P; Cerutti A
    Minerva Pediatr; 1980 Sep; 32(17):1057-67. PubMed ID: 7453688
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trial with arginine tidiacicate in symptomatic chronic persistent hepatitis.
    Rizzo S
    Int J Clin Pharmacol Res; 1986; 6(3):225-30. PubMed ID: 3527997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Silymarin in the treatment of acute viral hepatitis].
    Patera L
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):533-4. PubMed ID: 737788
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ultrastructural morphometric investigations on mouse liver after treatment with phalloidin and alpha-amanitin followed by application of silybin (author's transl)].
    Meiss R; Brauch F; Themann H
    Z Gastroenterol; 1981 Aug; 19(8):384-9. PubMed ID: 7281857
    [No Abstract]   [Full Text] [Related]  

  • 39. [Silymarin treatment of alcoholic liver disease].
    Orv Hetil; 1990 Jul; 131(29):1607-9. PubMed ID: 2392321
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of a water-soluble derivative of silymarin on morphological and functional alterations of mouse hepatocytes induced by Frog Virus 3 (author's transl)].
    Gendrault JL; Steffan AM; Elharrar M; Kirn A
    Arzneimittelforschung; 1979; 29(5):786-91. PubMed ID: 582977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.